Learn More
Medchemexpress LLC 17a-Hydroxypregnenolone (17-OHP5) | 387-79-1 | 99.61% | 332.48 | 100 MG

Supplier: Medchemexpress LLC HY113263100MG
17a-Hydroxypregnenolone (17-OHP5) is a metabolite of Pregnenolone and a precursor in the biosynthesis of Dehydroepiandrosterone. It acts as a substrate for the enzyme 3β-hydroxysteroid dehydrogenase (3β-HSD). This compound is formed from pregnenolone by cytochrome P450 (CYP) isoform CYP17A1 hydroxylase activity and subsequently converted to dehydroepiandrosterone by CYP17A1-mediated 17,20-lyase activity. Levels of 17a-hydroxypregnenolone are elevated in patients with type II 3β-hydroxysteroid dehydrogenase deficiency, which is a form of congenital adrenal hyperplasia.
- Metabolite of pregnenolone
- Precursor in dehydroepiandrosterone biosynthesis
- Substrate for 3β-hydroxysteroid dehydrogenase
- Formed by CYP17A1 hydroxylase activity
- Converted to dehydroepiandrosterone by CYP17A1-mediated 17,20-lyase activity
- Elevated in type II 3β-hydroxysteroid dehydrogenase deficiency
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.